BioTech 365

DECEMBER 29, 2021

Insights on the Vaccine Contract Manufacturing Global Market to 2027 – Featuring Ajinomoto Althea, Catalent and IDT Biologika Among Others – ResearchAndMarkets.com Insights on the Vaccine Contract Manufacturing Global Market to 2027 – Featuring Ajinomoto Althea, Catalent and IDT Biologika … Continue reading →

Contract Manufacturing 40

Contract Manufacturing Manufacturing Vaccination Vaccine 40

BioTech 365

MAY 27, 2021

Gene Therapies, Cell Therapies, and COVID-19 Vaccines Viral Vector Contract Manufacturing Outlook Report 2021: Spotlight on AstraZeneca’s COVID-19 Vaccine, Luxturna, Zolgensma, Emergent, Catalent – ResearchAndMarkets.com Gene Therapies, Cell Therapies, and COVID-19 Vaccines Viral Vector Contract Manufacturing Outlook Report 2021: Spotlight (..)

Contract Manufacturing 40

Contract Manufacturing Gene Therapy Vaccination Vaccine 40

BioTech 365

JANUARY 14, 2022

Outlook on the Biologics Contract Manufacturing Global Market to 2031 – Focus on Monoclonal Antibodies, Recombinant Proteins, Vaccines and Molecular Therapy – ResearchAndMarkets.com Outlook on the Biologics Contract Manufacturing Global Market to 2031 – Focus on Monoclonal Antibodies, Recombinant Proteins, … Continue reading (..)

Contract Manufacturing 40

Contract Manufacturing Protein Antibody Manufacturing 40

pharmaphorum

JANUARY 19, 2021

Supplies of COVID-19 vaccines are in the spotlight as countries across the world step up their immunisation campaigns against the pandemic. As vaccine manufacturers face unprecedented demand for their newly approved products, the race is on to provide enough shots for billions of people across the world.

Vaccination 89

Vaccination Vaccine Manufacturing Contract Manufacturing 89

The Pharma Data

OCTOBER 22, 2021

At least 24 million doses of the mRNA-based vaccine will be filled in 2022 into vials under sterile conditions at Novartis Technical Operations state-of-the-art facility in Ljubljana, Slovenia New agreement follows earlier supply agreement for the fill and finish of more than 50 million doses in 2021 at the Novartis Stein site in Switzerland.

Vaccination 52

Vaccination Vaccine Filler Manufacturing 52

XTalks

FEBRUARY 11, 2021

Amidst growing global shortages of COVID-19 vaccine supplies, inaugural (by way of authorizations/approvals) COVID-19 vaccine maker Pfizer is addressing the issue by working to cut the manufacturing time of its vaccine by almost half. Related: Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production.

Manufacturing 52

Manufacturing Vaccination Vaccine DNA 52

The Pharma Data

JULY 21, 2021

(NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as “Biovac,” a Cape Town-based, South African biopharmaceutical company, to manufacture the Pfizer-BioNTech COVID-19 Vaccine for distribution within the African Union. CEO and Co-founder of BioNTech.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

The Pharma Data

MARCH 8, 2022

and manufacturer Aspen SA Operations (Pty) Ltd, based in South Africa, to enable the first COVID-19 vaccine to be manufactured and made available by an African company for people living in Africa, with the goal of increasing COVID-19 vaccination rates across the continent.

Vaccination 40

Vaccination Vaccine Manufacturing Contract Manufacturing 40

The Pharma Data

DECEMBER 23, 2020

” Dr. Stanley Plotkin , Professor Emeritus at The Wistar Institute, said, “INOVIO’s DNA vaccine appeared to be quite safe with few significant reactions but yet induced both antibody and T cell responses to SARS-CoV-2.” . PLYMOUTH MEETING, Pa. , The participants were enrolled into 1.0

DNA 40

DNA Vaccination Vaccine Immune Response 40

Pharmaceutical Technology

APRIL 24, 2023

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. “Because of greater demand for biologics across the board, outsourcing will play a major role.”

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

Roots Analysis

JANUARY 15, 2024

Although biopharmaceuticals offer significant profit margins and have demonstrated the potential to treat a myriad of disease indications, they are generally associated with high costs of development and complex manufacturing protocols. Advanced and complex technologies are required for manufacturing, as well as testing of biopharmaceuticals.

Contract Manufacturing 40

Contract Manufacturing Manufacturing Production Development 40

Pharma Mirror

DECEMBER 9, 2021

Combatting the pandemic has highlighted the importance of the partnership between biopharma organizations and the contract manufacturing organizations (CMOs) that must flexibly handle outsourced production, which can come suddenly and often must quickly be ramped up.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Drugs Vaccination 130

pharmaphorum

JULY 15, 2022

In the final piece of a three-part series, Ben Hargreaves explores how manufacturing infrastructure was rapidly built up to the required capacity to ensure sufficient supply of COVID-19 vaccines, and what still remains to be done to improve vaccine equity globally. All angles. No unqualified success.

Vaccination 115

Vaccination Vaccine Manufacturing Production 115

Roots Analysis

AUGUST 16, 2023

The success of COVID-19 vaccines paved the path for mRNA-based drug products. However, synthesis and manufacturing of mRNA is fraught with several challenges as the production of such biomolecules is complex, cost intensive, requires specialized expertise and dedicated equipment.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Marketing RNA 52

Pharmaceutical Technology

JANUARY 30, 2023

This is mixed news for contract manufacturing organisations (CMOs), as large CMOs such as Thermo Fisher Scientific (Waltham, MA, US) and Catalent Inc (Somerset, NJ, US) are typically involved in the manufacture of the most innovative products. However, non-NME and biosimilar approvals increased in 2022.

Drugs 130

Drugs Manufacturing Contract Manufacturing FDA Approval 130

Pharmaceutical Technology

NOVEMBER 22, 2022

It is therefore to be expected that there are a far greater number of Chinese sites for API manufacturing for FDA and EMA innovator and biosimilar drugs than for dose manufacturing and packaging. Veklury’s API is being manufactured by Esteve Huayi Pharmaceutical (Zhejiang, China) and Flamma (Bergamo, Italy) in east coast sites.

Manufacturing 162

Manufacturing Gene Therapy Gene Contract Manufacturing 162

Pharmaceutical Technology

AUGUST 16, 2022

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis.

Gene Therapy 162

Gene Therapy Packaging Packaging Contract Packaging 162

Roots Analysis

FEBRUARY 20, 2022

Hence, many pharmaceutical companies outsource manufacturing of nanoparticles to third party organizations, called as contract manufacturers. Variety of services provided by contract manufacturers are as follows: Nanoparticles: Emerging Stars for Pharmaceutical Industry. Nanoparticles Contract Manufacturing.

Contract Manufacturing 52

Contract Manufacturing Bioavailability Manufacturing Drug Delivery Systems 52

Pharmaceutical Technology

MAY 29, 2023

GlobalData’s New Drug Approvals and Their Contract Manufacture report provides critical insight into the contract manufacturing organization (CMO) industry by analysing relative performance of major CMOs by number of drug and vaccine approvals, and the outsourcing propensity for New Molecular Entities (NMEs) includin Buy the report here.

Contract Manufacturing 100

Contract Manufacturing Drugs Manufacturing Vaccination 100

Pharma Mirror

MARCH 31, 2022

Symbiosis Pharmaceutical Services Ltd (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile global manufacture of pharmaceuticals, vaccines and biopharmaceuticals including Advanced Therapeutical Medicinal Products (ATMPs), has announced the completion of a £1.3

Manufacturing 130

Manufacturing Contract Manufacturing Gene Therapy Research 130

Pharmaceutical Technology

JULY 29, 2022

The need for the sector to rapidly research, develop and test new vaccines had always been of critical importance, but in the context of a global pandemic and national lockdowns, it became even more so, with each part of the supply chain required to face up to the full weight of the task.

Manufacturing 147

Manufacturing Production Engineer Contract Manufacturing 147

Pfizer

DECEMBER 13, 2021

Shot of a Lifetime: How Two Pfizer Manufacturing Plants Upscaled to Produce the COVID-19 Vaccine in Record Time. Shot of a Lifetime: How Two Pfizer Manufacturing Plants Upscaled to Produce the COVID-19 Vaccine in Record Time. They embarked on a sterilization process to make the vaccine safe for injection.

Manufacturing 52

Manufacturing Vaccination Vaccine Production 52

Pharmaceutical Technology

JUNE 6, 2023

GlobalData’s New Drug Approvals and Their Contract Manufacture report provides critical insight into the contract manufacturing organization (CMO) industry by analysing relative performance of major CMOs by number of drug and vaccine approvals, and the outsourcing propensity for New Molecular Entities (NMEs) includin Buy the report here.

Contract Manufacturing 100

Contract Manufacturing Drugs Manufacturing Vaccination 100

Pharmaceutical Technology

NOVEMBER 30, 2022

Each month, Pharmaceutical Technology takes a look at recent decisions taken by regulatory and reimbursement agencies and identifies the key manufacturing players that can be impacted by them. For this edition, Pharmaceutical Technology considers the regulatory decisions from late September through early November.

Manufacturing 130

Manufacturing Packaging Packaging Drugs 130

Pharmaceutical Technology

APRIL 4, 2023

Indian pharma manufacturing continues to be the backbone of drug supplies worldwide, and GlobalData analysis suggests US overreliance on the country for generic drug supply. Telangana’s pharma manufacturing industry is well established and continues to have more than double the pharma sites of Andhra Pradesh. © GlobalData.

Manufacturing 130

Manufacturing Generic Drugs Contract Manufacturing Production 130

Camargo

FEBRUARY 4, 2021

This situation reflects several issues with accelerated approvals, perhaps foretelling issues with the recent Emergency Use Authorizations (EUAs) of COVID-19 vaccines. For vaccines, the patient alone is involved in the risk assessment. In the instance of Makena, expecting mothers must also factor in their desire for a viable baby.

Development 131

Development Production Drugs Manufacturing 131

Pharmaceutical Technology

DECEMBER 27, 2022

Once lockdown measures eased and Covid-19 vaccines and boosters became available, the industry anticipated a significant recovery in the market and in the number of deals. This expansion could factor in deals with contract manufacturing organisations (CMOs) and other logistical companies.

Life Science 130

Life Science Marketing Manufacturing Contract Manufacturing 130

Pharmaceutical Technology

JANUARY 12, 2023

PM: Lyophilization is widely used in the pharmaceutical and biotech industry for small molecule drug products, vaccines, antibodies, and other biological material. What are the key advantages of this stabilization method? United Kingdom. United States. Afghanistan. Åland Islands. Albania.

Production 130

Production Contamination Development Manufacturing 130

Pharmaceutical Technology

DECEMBER 15, 2022

The Singapore Government has launched Biologics Pharma Innovation Programme Singapore (BioPIPS), which aims to increase the country’s manufacturing capacity for biologics, including recombinant proteins and vaccines. The organizations plan to use data analytics to improve manufacturing processes. Additionally, Merck & Co.

Manufacturing 264

Manufacturing Vaccination Vaccine Production 264

Bio Pharma Dive

SEPTEMBER 10, 2020

The contract manufacturer is riding a boom in demand for both its gene therapy and vaccine manufacturing services.

Gene Therapy 130

Gene Therapy Gene Contract Manufacturing Manufacturing 130

Pfizer

JANUARY 17, 2023

Upon completion of the construction, the state-of-the-art facility will have extensive capabilities for producing biologics drug substance and provides additional manufacturing capacity allowing Pfizer to help accelerate its innovative pipeline.

Manufacturing 85

Manufacturing Containment Development Medicine 85

Pharmaceutical Technology

MARCH 21, 2023

In such turbulent times, ensuring the most efficient and cost-effective manufacturing frameworks becomes even more important. Most pharmaceutical and biotech companies outsource certain production tasks to contract manufacturing organizations (CMOs).

Manufacturing 147

Manufacturing Drugs Packaging Packaging 147

XTalks

MAY 11, 2021

According to the company, $715 million of the investment will go towards expanding Lonza’s existing Visp facility where Lonza aims to increase large-scale biologics manufacturing capacity to meet customer demand in the contract manufacturing space.

Manufacturing 64

Manufacturing Contract Manufacturing Production Drugs 64

Fierce Pharma

FEBRUARY 22, 2024

. | To get a pulse on Moderna following its “year of transition” in 2023, look no further than the company’s manufacturing operations. The Cambridge, Massachusetts-based biotech has incurred a COVID-related wind-down charge on one hand, while it spends millions of dollars to bolster cancer vaccines at the same time.

Contract Manufacturing 77

Contract Manufacturing Manufacturing Production Vaccination 77

Roots Analysis

JANUARY 14, 2024

With the increased interest and gradual shift of investment from small molecule drugs to biologics and the establishment of several biologics manufacturing companies / biologics CMOs, more than 250 biologic therapies and vaccines have been developed, globally.

Contract Manufacturing 40

Contract Manufacturing Protein Manufacturing Production 40

Pharmaceutical Technology

DECEMBER 12, 2022

Pharmaceutical companies often outsource different parts of the manufacturing process, including the production of small molecule active pharmaceutical ingredients (APIs) and parenteral packaging, to contract manufacturing organizations (CMOs). Source: GlobalData Pharmaceutical Intelligence Center.

Manufacturing 147

Manufacturing Drugs Packaging Packaging 147

Roots Analysis

FEBRUARY 26, 2024

In fact, the share of biologics in the overall pharmaceutical contract manufacturing market has increased from 16% in 2006 to over 25% in 2017. Biologics constitute a majority of the top selling drugs and represent one of the fastest growing segments of the overall pharmaceutical industry.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Drugs Contract Manufacturing 52